NW Bio Proxy Statement Filed for June 27th Annual Meeting

TL;DR

NW BIO proxy filed for 6/27 meeting - shareholders vote on key company matters.

AI Summary

Northwest Biotherapeutics, Inc. filed a Definitive Proxy Statement (DEFA14A) on June 25, 2024, regarding its upcoming Annual Meeting of Stockholders. The filing indicates that the meeting will be held on June 27, 2024, and provides information on accessing the meeting via an audio-only connection. The company is seeking shareholder approval for various matters at this meeting.

Why It Matters

This filing is crucial for shareholders as it outlines the agenda and voting matters for the company's annual meeting, impacting corporate governance and future decisions.

Risk Assessment

Risk Level: medium — Proxy statements can signal upcoming strategic shifts or shareholder votes that may impact stock price, but this specific filing is procedural.

Key Players & Entities

• NORTHWEST BIOTHERAPEUTICS INC (company) — Registrant
• June 25, 2024 (date) — Filing Date
• June 27, 2024 (date) — Annual Meeting Date

FAQ

Filing Documents

• tm2418224d1_defa14a.htm (DEFA14A) — 14KB
• 0001104659-24-074824.txt ( ) — 15KB

From the Filing

As filed with the Securities and Exchange Commission on June 25, 2024 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to §240.14a-12 Northwest Biotherapeutics, Inc. (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. NORTHWEST BIOTHERAPEUTICS, INC. STATEMENT REGARDING ACCESS TO AUDIO-ONLY CONNECTION FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 29, 2024 Northwest Biotherapeutics, Inc. (the “Company”) is filing this supplemental disclosure to advise stockholders on how they may connect from a remote location through an audio-only link to the Annual Meeting of Stockholders to be held on Saturday, June 29, 2024 at 1:30 p.m. Eastern Time (the “Annual Meeting”). Stockholders who cannot attend the Annual Meeting in person will need to vote prior to the meeting as the audio-only link will not enable voting during the meeting. The Annual Meeting may be accessed by stockholders and guests in audio-only mode by accessing https://gibsondunn.zoom.us/j/94401295595 and entering passcode: 324816 . Alternatively, the Annual Meeting may be accessed telephonically in listening-only mode by dialing (669) 219-2599 or (669) 900-6833 and entering webinar ID: 944 0129 5595 and passcode: 324816 . Following the Annual Meeting, there will be an informal discussion period as time permits. Stockholders may submit written questions to the Company prior to 6:00 p.m. Eastern Time on Wednesday, June 26, 2024. The Company strongly encourages its eligible stockholders to vote and submit their proxies in advance of the Annual Meeting by methods described in the proxy materials distributed to stockholders on or about June 3, 2024. If stockholders have already voted, no additional action is required. Additional details regarding the Annual Meeting and the matters to be presented to stockholders at the Annual Meeting are available in the Company’s definitive proxy statement, filed with the Securities and Exchange Commission on June 3, 2024. Stockholders may also access the definitive proxy statement and other proxy materials by visiting: http://www.edocumentview.com/NWBO .